Skip to main content
Clinical Trials/NCT01283087
NCT01283087CompletedNot Applicable

Spinal Anesthesia Using Lidocaine and Sufentanil and TNS (=Transient Neurological Symptoms)

Vestre Viken Ringerike Sykehus2 sites in 1 country168 target enrollmentStarted: January 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
168
Locations
2
Primary Endpoint
Symptoms of transient neurological symptoms

Study Overview

Brief Summary

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • adults over the age of seventeen years

Exclusion Criteria

  • patient refuse spinal anesthesia
  • spinal anesthesia is contraindicated
  • pregnancy
  • patient is incapable of giving consent
  • neurological disorders
  • chronic pain
  • chronic use of analgesics
  • spinal anesthesia within five days before the actual surgery

Outcomes

Primary Outcomes

Symptoms of transient neurological symptoms

Time Frame: 5 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Vestre Viken Ringerike Sykehus
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Britt-Marie Berling

MD, PhD

Vestre Viken Ringerike Sykehus

Study Sites (2)

Loading locations...

Similar Trials